
PMGC Holdings Inc.
ELABHealthcare|Biotechnology|US
$1.61
-0.04 (-2.42%)
DCF Value
$847.13
Tangible Book / Share
$15.81
Cash / Share
$38.54
Financing Filings (last 12 months)
8
Shelf registrations / offering prospectuses — latest Apr 20, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
NorthStrive Biosciences Announces Results from EL-32 Preclinical Combination Study with Semaglutide and Plans for Next Phase of Development
Nov 5, 2026 · GlobeNewsWire
PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update
Oct 8, 2026 · GlobeNewsWire
PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy
Oct 1, 2026 · GlobeNewsWire
NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs
Sep 29, 2026 · GlobeNewsWire
PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings
Sep 18, 2026 · GlobeNewsWire
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
Sep 1, 2026 · GlobeNewsWire
PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio
Aug 26, 2026 · GlobeNewsWire
PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss
Aug 25, 2026 · GlobeNewsWire
NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight
Aug 21, 2026 · GlobeNewsWire
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split
Aug 19, 2026 · GlobeNewsWire
SEC Filings (146)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 2, 2026 | 8-K | Material event | DocumentIndex |
| Oct 28, 2026 | 8-K | Material event | DocumentIndex |
| Oct 22, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 29, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Sep 18, 2026 | 8-K | Material event | DocumentIndex |
| Sep 2, 2026 | 8-K | Material event | DocumentIndex |
| Aug 27, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 9, 2026 | 8-K | Material event | DocumentIndex |
| Jul 7, 2026 | 8-K | Material event | DocumentIndex |
| Jul 1, 2026 | 8-K | Material event | DocumentIndex |
| Jun 8, 2026 | 8-K | Material event | DocumentIndex |
| Jun 5, 2026 | 8-K | Material event | DocumentIndex |
| Jun 3, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jun 3, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| May 27, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| May 4, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| May 4, 2026 | DEF 14C | DocumentIndex | |
| Apr 28, 2026 | 8-K | Material event | DocumentIndex |
| Apr 27, 2026 | DEF 14C | DocumentIndex | |
| Apr 24, 2026 | PRE 14C | DocumentIndex | |
| Apr 23, 2026 | 8-K | Material event | DocumentIndex |
| Apr 21, 2026 | 8-K | Material event | DocumentIndex |
| Apr 20, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Apr 17, 2026 | PRE 14C | DocumentIndex | |
| Apr 17, 2026 | 8-K | Material event | DocumentIndex |
| Apr 9, 2026 | 8-K | Material event | DocumentIndex |
| Apr 8, 2026 | 8-K | Material event | DocumentIndex |
| Apr 6, 2026 | 8-K | Material event | DocumentIndex |
| Apr 2, 2026 | 8-K | Material event | DocumentIndex |
| Apr 1, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 31, 2026 | 8-K | Material event | DocumentIndex |
| Mar 30, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 27, 2026 | 8-K | Material event | DocumentIndex |
| Mar 24, 2026 | 8-K | Material event | DocumentIndex |
| Mar 23, 2026 | 8-K | Material event | DocumentIndex |